Health
BAT’s COVID-19 vaccine candidate gets FDA approval for human study – Reuters
British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug…
By Reuters Staff
Dec 16 (Reuters) – British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug Administration for Phase I human study.
The Worlds No.2 cigarette company had earlier this year said it was working on a COVID-19 vaccine using proteins extracted from tobacco leaves.
The company said the enrolment for the study is expected to begin shortly.
-
General23 hours agoNothing to see here *wink wink*
-
General22 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
Noosa News8 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News17 hours agoWhat time does the NRL grand final kick off? When is the NRLW grand final?